Applied Photonix Launches ViroZap®, the First FDA-Cleared Medical Device for Hospital-Wide Air Disinfection
Hospital-grade air disinfection technology now available for homes, schools, offices, and healthcare facilities - integrating directly into existing HVAC systems
[TAMPA, FLORIDA] - [SEPTEMBER 3, 2026] — Applied Photonix today announced the commercial launch of ViroZap®, the first FDA-cleared, Class II medical device engineered for in-duct air disinfection. Unlike standalone air purifiers, ViroZap integrates directly into new or existing HVAC systems, delivering continuous, whole-building air treatment without the need for room-by-room units.
ViroZap was developed by Dr. Yogi Goswami, Distinguished University Professor at the University of South Florida and a member of the National Inventors Hall of Fame.
Proven Performance, Third-Generation Technology
Built on third-generation plasmonic photonic technology, ViroZap treats recirculated air continuously and at low energy cost. The device does not use UV-C light, which can cause retinal damage, burn the skin. Some UV-C systems also produce ozone, which can irritate the lungs. ViroZap uses safe, UV-A light and does not produce ozone.
At an airflow rate of 500 CFM, independent testing confirms:
99.9995% reduction of airborne RNA/DNA viruses
99.9997% reduction of airborne bacteria (gram-positive and gram-negative)
99.995% reduction of mold and fungal spores
Rapid VOC detoxification, with no ozone byproduct
Engineered for Real-World HVAC Integration
ViroZap meets ASHRAE Standard 241 and ASHRAE Standard 170 and is pressure-drop neutral, operating seamlessly with standard MERV 13/15 filtration and a MERV 8 pre-filter. A custom coated HEPA option is also available. The system scales from single-family residential installations to large hospital, school, and institutional HVAC systems.
"ViroZap represents a fundamental shift in how we think about indoor air quality — from filtration alone to active, continuous disinfection at the source," said Terry Murray, Vice President of Sales & Marketing, Applied Photonix. "With FDA clearance as a Class II medical device, we're able to bring hospital-grade air safety to the spaces people spend the most time in: their homes, schools, offices, and of course, healthcare facilities."
Availability and Partnership Opportunities
ViroZap is now available for commercial deployment. Applied Photonix is actively seeking distribution and installation partners across the United States and internationally to support growing demand across residential, commercial, education, and healthcare markets.
About Applied Photonix
Applied Photonix develops advanced photonic technologies for indoor air quality and disinfection. Its flagship product, ViroZap®, is the first FDA-cleared, Class II medical device for in-duct air disinfection, delivering hospital-grade air treatment through existing HVAC infrastructure.
For more information, please contact us at terry@aphotonix.com or direct moble (828) 808-2955.
Comments